Skip Nav Destination
Issues
Acta Haematologica 2019, Vol. 141, No. 2
Editorial Comment
Ankyrin Mutations in Hereditary Spherocytosis
Acta Haematol (2019) 141 (2): 63–64.
https://doi.org/10.1159/000495339
Brief Communication
Original Paper
Brief Communication
Autoimmune Cytopenias Occurring after Treatment with Chemoimmunotherapy for Non-Hodgkin Lymphomas
Acta Haematol (2019) 141 (2): 79–83.
https://doi.org/10.1159/000495600
Original Paper
Efficacy of Gemcitabine as Salvage Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma
Acta Haematol (2019) 141 (2): 84–90.
https://doi.org/10.1159/000495283
Editorial Comment
Gemcitabine: End of a Chemotherapy’s Era?
Acta Haematol (2019) 141 (2): 91–92.
https://doi.org/10.1159/000496098
Review
Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis
Acta Haematol (2019) 141 (2): 93–106.
https://doi.org/10.1159/000495455
Case Report
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib
Firas El Chaer; Noa G. Holtzman; Edward A. Sausville; Jennie Y. Law; Seung Tae Lee; Vu H. Duong; Maria R. Baer; Rima Koka; Zeba N. Singh; Nancy M. Hardy; Ashkan Emadi
Acta Haematol (2019) 141 (2): 107–110.
https://doi.org/10.1159/000495558
Original Paper
Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial
Keisuke Tanaka; Shigeo Toyota; Megumi Akiyama; Naoki Wakimoto; Yuichi Nakamura; Yuho Najima; Noriko Doki; Kazuhiko Kakihana; Aiko Igarashi; Takeshi Kobayashi; Kazuteru Ohashi; Daisuke Kudo; Atsushi Shinagawa; Hina Takano; Takayuki Fujio; Yasushi Okoshi; Mitsuo Hori; Takashi Kumagai; Tatsuya Saito; Junichi Mukae; Koh Yamamoto; Ikuyo Tsutsumi; Takuya Komeno; Chikashi Yoshida; Masahide Yamamoto; Hiroshi Kojima; on behalf of the Ochanomizu Hematology Study Group
Acta Haematol (2019) 141 (2): 111–118.
https://doi.org/10.1159/000495338
Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene
Bella Bielorai; Moshe Leitner; Gal Goldstein; Ruty Mehrian-Shai; Luba Trakhtenbrot; Tamar Fisher; Victoria Marcu; Michal Yalon; Ginette Schiby; Ortal Barel; Nitzan Cal; Hana Golan; Amos Toren
Acta Haematol (2019) 141 (2): 119–127.
https://doi.org/10.1159/000495687
